Close

Neothetics (NEOT) Prices Upsized IPO at $14, Middle of Range

November 20, 2014 8:06 AM EST

Neothetics (NASDAQ: NEOT) priced its initial public offering of 4,650,000 shares of its common stock at a public offering price of $14.00 per share, the middle of the expected $13-$15 range. The offer size was raised from 4,300,000 shares. The shares are scheduled to begin trading on The NASDAQ Global Market today under the symbol "NEOT."

Piper Jaffray & Co. and Guggenheim Securities, LLC, are acting as joint book-running managers for the offering. Needham & Company is acting as a co-manager.

Neothetics is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. The lead product candidate, LIPO-202, is for the reduction of subcutaneous fat in the central abdomen in non-obese patients, an indication for which there is no FDA-approved drug. If approved, LIPO-202 may be a best-in-class non-surgical, non-ablative procedure and first-in-class injectable formulation for localized fat reduction and body contouring.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

IPOs

Related Entities

Piper Jaffray, Needham & Company, IPO